$BKKT Bakkt (BKXT) shares closed significantly higher on Friday, rising over 15% to $8.59. The stock currently holds a market capitalization of approximately $387 million. This price action followed recent operational updates indicating a positive shift in the company's business strategy.

On September 9, the company expanded its global commercial team and revised its 2026 full-year Total Transacting Volume (TTV) target upward from $2.5 billion to $3 billion. Management cited stronger-than-expected demand and a larger pipeline of opportunities. They also noted that several large opportunities are still in early stages and have not yet contributed significant volume.

The company's financial results released on August 10 showed GAAP net income of $80.8 million. This figure was primarily driven by a $98.5 million non-cash fair value gain on Transchem warrants. Quarterly TTV stood at $168.8 million, bringing first-half TTV to $410.0 million.

In recent months, Bakkt has also made several strategic moves. The company appointed Matt White as Chief Financial Officer in August. It completed its all-stock acquisition of Distributed Technologies Research in April. Additionally, it secured Indian regulatory approval for its strategic investment in Transchem in June.

Looking at the weekly chart, the stock has recovered from its low of $6.72 but remains well below its 52-week high of $49.79. The current price trades below its major weekly moving averages, including the 30-day EMA at $9.28 and the 60-day EMA at $10.84. The SuperTrend indicator sits higher at $12.55. This technical picture suggests that while short-term momentum has improved, medium-term resistance remains.

#USAStocksRally #Gate广场中秋团圆局 #GateSquareMidAutumnReunion #ShareWeekly

DYOR 🔎 NFA ✔️